The session featured a study comparing MRI criteria for diagnosing MS, the role of spinal cord volume loss in predicting disease activity, and more.
New research covers treating MS early, identifying those at risk for AED-induced psychosis, & selecting a drug for epilepsy patients with migraines.
Our August news includes a potential classification system for Alzheimer disease, new findings in a 3D model of TBI, and migraine treatments.
Recent neurological studies outline a link between TBI and Parkinson disease, discuss neuroimaging to predict recovery, and warn against DIY tDCS.
Our July news includes the Alzheimer-diabetes link, increased rates of Parkinson, and guidelines for acute migraine treatment in the ED.
Three studies regarding stroke look at blood pressure trajectories, use of occlusion, and the advantage of conscious sedation over general anesthesia.
Neurologic conditions, such as epilepsy, migraine, and stroke, often have real-world consequences, such as those described in three new studies.
Our May news includes memory replay disruption in Alzheimer disease, impulse control disorder in Parkinson disease, and return to play in TBI.
From no evidence of disease activity in MS to studies of a new treatment for periodic paralysis, AAN 2016 featured many exciting clinical trials.
Two authors of the updated AAN guidelines for treatment with botulinum neurotoxin discussed their findings and potential avenues of further research.